Arcturus Therapeutics Holdings, Inc. (ARCT)
15.19
-0.98
(-6.06%)
USD |
NASDAQ |
Aug 28, 16:00
15.18
-0.01
(-0.07%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Total Assets (Quarterly) : 224.31M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 224.31M |
| March 31, 2026 | 245.41M |
| December 31, 2025 | 271.15M |
| September 30, 2025 | 282.34M |
| June 30, 2025 | 309.27M |
| March 31, 2025 | 331.78M |
| December 31, 2024 | 344.07M |
| September 30, 2024 | 370.65M |
| June 30, 2024 | 388.61M |
| March 31, 2024 | 418.85M |
| December 31, 2023 | 429.40M |
| September 30, 2023 | 457.65M |
| June 30, 2023 | 430.65M |
| March 31, 2023 | 470.86M |
| December 31, 2022 | 450.39M |
| September 30, 2022 | 293.63M |
| June 30, 2022 | 337.01M |
| March 31, 2022 | 341.99M |
| December 31, 2021 | 392.81M |
| September 30, 2021 | 434.54M |
| June 30, 2021 | 448.81M |
| March 31, 2021 | 481.47M |
| December 31, 2020 | 476.46M |
| September 30, 2020 | 322.52M |
| June 30, 2020 | 149.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 72.10M |
| December 31, 2019 | 82.14M |
| September 30, 2019 | 87.22M |
| June 30, 2019 | 70.94M |
| March 31, 2019 | 44.42M |
| December 31, 2018 | 44.20M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 52.02M |
| September 30, 2017 | 40.59M |
| June 30, 2017 | 42.35M |
| March 31, 2017 | 46.42M |
| December 31, 2016 | 51.57M |
| September 30, 2016 | 55.91M |
| June 30, 2016 | 62.69M |
| March 31, 2016 | 67.10M |
| December 31, 2015 | 71.68M |
| September 30, 2015 | 37.65M |
| June 30, 2015 | 41.62M |
| March 31, 2015 | |
| December 31, 2014 | 22.32M |
| September 30, 2014 | 30.86M |
| June 30, 2014 | 40.17M |
| March 31, 2014 | 45.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Exelixis, Inc. | 2.494B |
| PTC Therapeutics, Inc. | 3.250B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 52.50M |
| Shareholders Equity (Quarterly) | 171.81M |
| Debt to Equity Ratio | 0.1335 |
| Current Ratio | 5.879 |
| Net Debt Paydown Yield | 2.07% |